Benutzer: Gast  Login
Titel:

Effect of abciximab on clinical and angiographic restenosis in patients with non-ST-segment elevation acute coronary syndromes.

Dokumenttyp:
Journal Article; Randomized Controlled Trial; Article
Autor(en):
Iijima, R; Ndrepepa, G; Mehilli, J; Dirschinger, J; Pache, J; Seyfarth, M; Schömig, A; Kastrati, A
Abstract:
The ISAR-REACT 2 trial was designed to assess the effect of abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after a 600-mg loading dose of clopidogrel. The aim of the present study was to investigate the impact of abciximab on clinical and angiographic restenosis after coronary stenting in patients with acute coronary syndromes. The angiographic substudy included 1,544 patients from the ISAR-REACT 2 trial randomly assigned to abciximab (771 patie...     »
Zeitschriftentitel:
Am J Cardiol
Jahr:
2008
Band / Volume:
101
Heft / Issue:
9
Seitenangaben Beitrag:
1226-31
Sprache:
eng
Volltext / DOI:
doi:10.1016/j.amjcard.2007.12.019
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/18435948
Print-ISSN:
0002-9149
TUM Einrichtung:
I. Medizinische Klinik und Poliklinik (Kardiologie)
 BibTeX